nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—NAT2—urinary bladder cancer	0.605	1	CbGaD
Isoniazid—CYP2A6—Fluorouracil—urinary bladder cancer	0.0382	0.205	CbGbCtD
Isoniazid—CYP3A4—Thiotepa—urinary bladder cancer	0.0235	0.126	CbGbCtD
Isoniazid—CYP2E1—Etoposide—urinary bladder cancer	0.021	0.113	CbGbCtD
Isoniazid—CYP2C8—Fluorouracil—urinary bladder cancer	0.0188	0.101	CbGbCtD
Isoniazid—CYP2C8—Etoposide—urinary bladder cancer	0.0157	0.0845	CbGbCtD
Isoniazid—NAT2—urine—urinary bladder cancer	0.015	0.342	CbGeAlD
Isoniazid—CYP1A2—Fluorouracil—urinary bladder cancer	0.0146	0.0784	CbGbCtD
Isoniazid—CYP2C9—Fluorouracil—urinary bladder cancer	0.0131	0.0707	CbGbCtD
Isoniazid—CYP1A2—Etoposide—urinary bladder cancer	0.0122	0.0654	CbGbCtD
Isoniazid—CYP2C9—Cisplatin—urinary bladder cancer	0.0112	0.06	CbGbCtD
Isoniazid—CYP2D6—Doxorubicin—urinary bladder cancer	0.00684	0.0368	CbGbCtD
Isoniazid—CYP3A4—Etoposide—urinary bladder cancer	0.00638	0.0343	CbGbCtD
Isoniazid—CYP3A4—Doxorubicin—urinary bladder cancer	0.00435	0.0234	CbGbCtD
Isoniazid—NAT2—renal system—urinary bladder cancer	0.00366	0.0836	CbGeAlD
Isoniazid—CYP2C19—urine—urinary bladder cancer	0.003	0.0686	CbGeAlD
Isoniazid—CYP1A2—urine—urinary bladder cancer	0.00245	0.056	CbGeAlD
Isoniazid—CYP2C9—urine—urinary bladder cancer	0.00233	0.0532	CbGeAlD
Isoniazid—CYP2E1—urine—urinary bladder cancer	0.00221	0.0504	CbGeAlD
Isoniazid—CYP3A4—urine—urinary bladder cancer	0.00178	0.0405	CbGeAlD
Isoniazid—CYP2D6—urine—urinary bladder cancer	0.00175	0.0399	CbGeAlD
Isoniazid—CYP2A6—prostate gland—urinary bladder cancer	0.00168	0.0383	CbGeAlD
Isoniazid—Neurotoxicity—Gemcitabine—urinary bladder cancer	0.00162	0.0235	CcSEcCtD
Isoniazid—Neurotoxicity—Cisplatin—urinary bladder cancer	0.00151	0.0219	CcSEcCtD
Isoniazid—Emotional distress—Fluorouracil—urinary bladder cancer	0.00145	0.0211	CcSEcCtD
Isoniazid—CYP2A6—seminal vesicle—urinary bladder cancer	0.00142	0.0324	CbGeAlD
Isoniazid—Neurotoxicity—Etoposide—urinary bladder cancer	0.00138	0.0201	CcSEcCtD
Isoniazid—Metabolic acidosis—Etoposide—urinary bladder cancer	0.00136	0.0197	CcSEcCtD
Isoniazid—Hyperglycaemia—Valrubicin—urinary bladder cancer	0.00122	0.0177	CcSEcCtD
Isoniazid—Eruption—Gemcitabine—urinary bladder cancer	0.00102	0.0148	CcSEcCtD
Isoniazid—Reaction gastrointestinal—Methotrexate—urinary bladder cancer	0.000962	0.014	CcSEcCtD
Isoniazid—Diabetic—Methotrexate—urinary bladder cancer	0.000962	0.014	CcSEcCtD
Isoniazid—Optic neuritis—Cisplatin—urinary bladder cancer	0.000951	0.0138	CcSEcCtD
Isoniazid—Memory impairment—Thiotepa—urinary bladder cancer	0.000951	0.0138	CcSEcCtD
Isoniazid—Ill-defined disorder—Valrubicin—urinary bladder cancer	0.000874	0.0127	CcSEcCtD
Isoniazid—Optic neuritis—Etoposide—urinary bladder cancer	0.000871	0.0127	CcSEcCtD
Isoniazid—Malaise—Valrubicin—urinary bladder cancer	0.000849	0.0123	CcSEcCtD
Isoniazid—Neuritis—Gemcitabine—urinary bladder cancer	0.000841	0.0122	CcSEcCtD
Isoniazid—Neurotoxicity—Methotrexate—urinary bladder cancer	0.000828	0.012	CcSEcCtD
Isoniazid—CYP2A6—vagina—urinary bladder cancer	0.000828	0.0189	CbGeAlD
Isoniazid—Hyperbilirubinaemia—Thiotepa—urinary bladder cancer	0.000821	0.0119	CcSEcCtD
Isoniazid—CYP2E1—prostate gland—urinary bladder cancer	0.000792	0.0181	CbGeAlD
Isoniazid—Discomfort—Valrubicin—urinary bladder cancer	0.000792	0.0115	CcSEcCtD
Isoniazid—Neurotoxicity—Epirubicin—urinary bladder cancer	0.000775	0.0113	CcSEcCtD
Isoniazid—Neurotoxicity—Doxorubicin—urinary bladder cancer	0.000717	0.0104	CcSEcCtD
Isoniazid—Liver injury—Cisplatin—urinary bladder cancer	0.000695	0.0101	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Gemcitabine—urinary bladder cancer	0.00069	0.01	CcSEcCtD
Isoniazid—CYP2E1—seminal vesicle—urinary bladder cancer	0.00067	0.0153	CbGeAlD
Isoniazid—Vasculitis—Gemcitabine—urinary bladder cancer	0.000643	0.00935	CcSEcCtD
Isoniazid—CYP2C8—renal system—urinary bladder cancer	0.000642	0.0146	CbGeAlD
Isoniazid—Feeling abnormal—Valrubicin—urinary bladder cancer	0.000633	0.0092	CcSEcCtD
Isoniazid—Body temperature increased—Valrubicin—urinary bladder cancer	0.000607	0.00883	CcSEcCtD
Isoniazid—Ill-defined disorder—Mitomycin—urinary bladder cancer	0.000602	0.00875	CcSEcCtD
Isoniazid—CYP1A2—renal system—urinary bladder cancer	0.0006	0.0137	CbGeAlD
Isoniazid—Hepatocellular injury—Cisplatin—urinary bladder cancer	0.000585	0.0085	CcSEcCtD
Isoniazid—Malaise—Mitomycin—urinary bladder cancer	0.000585	0.0085	CcSEcCtD
Isoniazid—Body temperature increased—Carboplatin—urinary bladder cancer	0.000563	0.00817	CcSEcCtD
Isoniazid—Asthenia—Valrubicin—urinary bladder cancer	0.000551	0.00801	CcSEcCtD
Isoniazid—Discomfort—Mitomycin—urinary bladder cancer	0.000546	0.00793	CcSEcCtD
Isoniazid—CYP2E1—renal system—urinary bladder cancer	0.00054	0.0123	CbGeAlD
Isoniazid—CYP2C19—vagina—urinary bladder cancer	0.000532	0.0122	CbGeAlD
Isoniazid—CYP2E1—urethra—urinary bladder cancer	0.000531	0.0121	CbGeAlD
Isoniazid—Eruption—Methotrexate—urinary bladder cancer	0.000522	0.00758	CcSEcCtD
Isoniazid—Hepatic function abnormal—Gemcitabine—urinary bladder cancer	0.000521	0.00758	CcSEcCtD
Isoniazid—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.000518	0.00753	CcSEcCtD
Isoniazid—CYP2C8—female reproductive system—urinary bladder cancer	0.000514	0.0117	CbGeAlD
Isoniazid—Anorexia—Mitomycin—urinary bladder cancer	0.000505	0.00733	CcSEcCtD
Isoniazid—Vomiting—Valrubicin—urinary bladder cancer	0.000489	0.0071	CcSEcCtD
Isoniazid—Eruption—Epirubicin—urinary bladder cancer	0.000488	0.0071	CcSEcCtD
Isoniazid—Optic neuritis—Epirubicin—urinary bladder cancer	0.000488	0.0071	CcSEcCtD
Isoniazid—Rash—Valrubicin—urinary bladder cancer	0.000485	0.00704	CcSEcCtD
Isoniazid—CYP2C8—vagina—urinary bladder cancer	0.000465	0.0106	CbGeAlD
Isoniazid—Decreased appetite—Mitomycin—urinary bladder cancer	0.00046	0.00669	CcSEcCtD
Isoniazid—Nausea—Valrubicin—urinary bladder cancer	0.000456	0.00663	CcSEcCtD
Isoniazid—Fatigue—Mitomycin—urinary bladder cancer	0.000456	0.00663	CcSEcCtD
Isoniazid—CYP2C9—female reproductive system—urinary bladder cancer	0.000456	0.0104	CbGeAlD
Isoniazid—Eruption—Doxorubicin—urinary bladder cancer	0.000452	0.00657	CcSEcCtD
Isoniazid—Optic neuritis—Doxorubicin—urinary bladder cancer	0.000452	0.00657	CcSEcCtD
Isoniazid—Feeling abnormal—Mitomycin—urinary bladder cancer	0.000436	0.00634	CcSEcCtD
Isoniazid—CYP3A4—renal system—urinary bladder cancer	0.000435	0.00992	CbGeAlD
Isoniazid—CYP2E1—female reproductive system—urinary bladder cancer	0.000433	0.00987	CbGeAlD
Isoniazid—CYP2D6—renal system—urinary bladder cancer	0.000428	0.00976	CbGeAlD
Isoniazid—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.000422	0.00614	CcSEcCtD
Isoniazid—Body temperature increased—Mitomycin—urinary bladder cancer	0.000419	0.00608	CcSEcCtD
Isoniazid—Jaundice—Thiotepa—urinary bladder cancer	0.000407	0.00591	CcSEcCtD
Isoniazid—Neuritis—Epirubicin—urinary bladder cancer	0.000402	0.00585	CcSEcCtD
Isoniazid—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00039	0.00566	CcSEcCtD
Isoniazid—Eosinophilia—Fluorouracil—urinary bladder cancer	0.000383	0.00557	CcSEcCtD
Isoniazid—Asthenia—Mitomycin—urinary bladder cancer	0.00038	0.00552	CcSEcCtD
Isoniazid—Neuritis—Doxorubicin—urinary bladder cancer	0.000372	0.00541	CcSEcCtD
Isoniazid—Liver injury—Epirubicin—urinary bladder cancer	0.000357	0.00519	CcSEcCtD
Isoniazid—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.000355	0.00516	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Methotrexate—urinary bladder cancer	0.000353	0.00513	CcSEcCtD
Isoniazid—CYP3A4—female reproductive system—urinary bladder cancer	0.000348	0.00795	CbGeAlD
Isoniazid—Neuropathy peripheral—Gemcitabine—urinary bladder cancer	0.000344	0.005	CcSEcCtD
Isoniazid—CYP2D6—female reproductive system—urinary bladder cancer	0.000342	0.00782	CbGeAlD
Isoniazid—Neuropathy peripheral—Fluorouracil—urinary bladder cancer	0.000338	0.00492	CcSEcCtD
Isoniazid—Vomiting—Mitomycin—urinary bladder cancer	0.000337	0.00489	CcSEcCtD
Isoniazid—Rash—Mitomycin—urinary bladder cancer	0.000334	0.00485	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Epirubicin—urinary bladder cancer	0.00033	0.0048	CcSEcCtD
Isoniazid—Liver injury—Doxorubicin—urinary bladder cancer	0.00033	0.0048	CcSEcCtD
Isoniazid—Vasculitis—Methotrexate—urinary bladder cancer	0.000329	0.00478	CcSEcCtD
Isoniazid—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.000328	0.00476	CcSEcCtD
Isoniazid—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.000322	0.00468	CcSEcCtD
Isoniazid—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.000321	0.00466	CcSEcCtD
Isoniazid—Nausea—Mitomycin—urinary bladder cancer	0.000314	0.00457	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Doxorubicin—urinary bladder cancer	0.000306	0.00444	CcSEcCtD
Isoniazid—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.000301	0.00438	CcSEcCtD
Isoniazid—Hepatocellular injury—Epirubicin—urinary bladder cancer	0.0003	0.00437	CcSEcCtD
Isoniazid—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.000294	0.00427	CcSEcCtD
Isoniazid—Jaundice—Etoposide—urinary bladder cancer	0.000292	0.00425	CcSEcCtD
Isoniazid—Gynaecomastia—Methotrexate—urinary bladder cancer	0.000287	0.00417	CcSEcCtD
Isoniazid—Convulsion—Thiotepa—urinary bladder cancer	0.000283	0.00411	CcSEcCtD
Isoniazid—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.000282	0.0041	CcSEcCtD
Isoniazid—Agranulocytosis—Etoposide—urinary bladder cancer	0.00028	0.00407	CcSEcCtD
Isoniazid—Hepatocellular injury—Doxorubicin—urinary bladder cancer	0.000278	0.00404	CcSEcCtD
Isoniazid—Lymphadenopathy—Methotrexate—urinary bladder cancer	0.000273	0.00397	CcSEcCtD
Isoniazid—Diabetes mellitus—Methotrexate—urinary bladder cancer	0.000268	0.00389	CcSEcCtD
Isoniazid—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.000261	0.00379	CcSEcCtD
Isoniazid—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000261	0.00379	CcSEcCtD
Isoniazid—Lymphadenopathy—Epirubicin—urinary bladder cancer	0.000256	0.00371	CcSEcCtD
Isoniazid—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.000255	0.0037	CcSEcCtD
Isoniazid—Anorexia—Thiotepa—urinary bladder cancer	0.000254	0.00369	CcSEcCtD
Isoniazid—Diabetes mellitus—Epirubicin—urinary bladder cancer	0.000251	0.00364	CcSEcCtD
Isoniazid—Hepatic function abnormal—Epirubicin—urinary bladder cancer	0.00025	0.00363	CcSEcCtD
Isoniazid—Malaise—Gemcitabine—urinary bladder cancer	0.000247	0.0036	CcSEcCtD
Isoniazid—Paraesthesia—Thiotepa—urinary bladder cancer	0.000239	0.00347	CcSEcCtD
Isoniazid—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.000237	0.00345	CcSEcCtD
Isoniazid—Lymphadenopathy—Doxorubicin—urinary bladder cancer	0.000237	0.00344	CcSEcCtD
Isoniazid—Dyspepsia—Thiotepa—urinary bladder cancer	0.000234	0.00341	CcSEcCtD
Isoniazid—Convulsion—Fluorouracil—urinary bladder cancer	0.000234	0.0034	CcSEcCtD
Isoniazid—Diabetes mellitus—Doxorubicin—urinary bladder cancer	0.000232	0.00337	CcSEcCtD
Isoniazid—Decreased appetite—Thiotepa—urinary bladder cancer	0.000231	0.00336	CcSEcCtD
Isoniazid—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.000231	0.00336	CcSEcCtD
Isoniazid—Discomfort—Gemcitabine—urinary bladder cancer	0.000231	0.00335	CcSEcCtD
Isoniazid—Malaise—Cisplatin—urinary bladder cancer	0.000231	0.00335	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00023	0.00334	CcSEcCtD
Isoniazid—Fatigue—Thiotepa—urinary bladder cancer	0.00023	0.00334	CcSEcCtD
Isoniazid—Discomfort—Fluorouracil—urinary bladder cancer	0.000227	0.0033	CcSEcCtD
Isoniazid—Convulsion—Cisplatin—urinary bladder cancer	0.000222	0.00322	CcSEcCtD
Isoniazid—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000219	0.00319	CcSEcCtD
Isoniazid—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000219	0.00319	CcSEcCtD
Isoniazid—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000217	0.00316	CcSEcCtD
Isoniazid—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000216	0.00313	CcSEcCtD
Isoniazid—Discomfort—Cisplatin—urinary bladder cancer	0.000215	0.00313	CcSEcCtD
Isoniazid—Anorexia—Gemcitabine—urinary bladder cancer	0.000213	0.0031	CcSEcCtD
Isoniazid—Malaise—Etoposide—urinary bladder cancer	0.000211	0.00307	CcSEcCtD
Isoniazid—Body temperature increased—Thiotepa—urinary bladder cancer	0.00021	0.00306	CcSEcCtD
Isoniazid—Anorexia—Fluorouracil—urinary bladder cancer	0.00021	0.00305	CcSEcCtD
Isoniazid—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000204	0.00297	CcSEcCtD
Isoniazid—Convulsion—Etoposide—urinary bladder cancer	0.000203	0.00295	CcSEcCtD
Isoniazid—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000201	0.00292	CcSEcCtD
Isoniazid—Eosinophilia—Methotrexate—urinary bladder cancer	0.000199	0.0029	CcSEcCtD
Isoniazid—Anorexia—Cisplatin—urinary bladder cancer	0.000199	0.00289	CcSEcCtD
Isoniazid—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000198	0.00287	CcSEcCtD
Isoniazid—Discomfort—Etoposide—urinary bladder cancer	0.000197	0.00286	CcSEcCtD
Isoniazid—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000196	0.00285	CcSEcCtD
Isoniazid—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000195	0.00283	CcSEcCtD
Isoniazid—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000194	0.00282	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000193	0.00281	CcSEcCtD
Isoniazid—Fatigue—Gemcitabine—urinary bladder cancer	0.000193	0.00281	CcSEcCtD
Isoniazid—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000191	0.00278	CcSEcCtD
Isoniazid—Asthenia—Thiotepa—urinary bladder cancer	0.000191	0.00278	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00019	0.00276	CcSEcCtD
Isoniazid—Paraesthesia—Cisplatin—urinary bladder cancer	0.000187	0.00272	CcSEcCtD
Isoniazid—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000187	0.00272	CcSEcCtD
Isoniazid—Eosinophilia—Epirubicin—urinary bladder cancer	0.000187	0.00271	CcSEcCtD
Isoniazid—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000185	0.00268	CcSEcCtD
Isoniazid—Anorexia—Etoposide—urinary bladder cancer	0.000182	0.00265	CcSEcCtD
Isoniazid—Decreased appetite—Cisplatin—urinary bladder cancer	0.000181	0.00264	CcSEcCtD
Isoniazid—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000181	0.00264	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00018	0.00262	CcSEcCtD
Isoniazid—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000177	0.00257	CcSEcCtD
Isoniazid—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000174	0.00253	CcSEcCtD
Isoniazid—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000173	0.00251	CcSEcCtD
Isoniazid—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000172	0.0025	CcSEcCtD
Isoniazid—Paraesthesia—Etoposide—urinary bladder cancer	0.000172	0.0025	CcSEcCtD
Isoniazid—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.00017	0.00247	CcSEcCtD
Isoniazid—Vomiting—Thiotepa—urinary bladder cancer	0.000169	0.00246	CcSEcCtD
Isoniazid—Rash—Thiotepa—urinary bladder cancer	0.000168	0.00244	CcSEcCtD
Isoniazid—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000168	0.00244	CcSEcCtD
Isoniazid—Decreased appetite—Etoposide—urinary bladder cancer	0.000166	0.00242	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000165	0.0024	CcSEcCtD
Isoniazid—Body temperature increased—Cisplatin—urinary bladder cancer	0.000165	0.0024	CcSEcCtD
Isoniazid—Fatigue—Etoposide—urinary bladder cancer	0.000165	0.0024	CcSEcCtD
Isoniazid—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000165	0.00239	CcSEcCtD
Isoniazid—Jaundice—Epirubicin—urinary bladder cancer	0.000164	0.00238	CcSEcCtD
Isoniazid—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000162	0.00236	CcSEcCtD
Isoniazid—Hepatitis—Methotrexate—urinary bladder cancer	0.000161	0.00234	CcSEcCtD
Isoniazid—Asthenia—Gemcitabine—urinary bladder cancer	0.000161	0.00233	CcSEcCtD
Isoniazid—Nausea—Thiotepa—urinary bladder cancer	0.000158	0.0023	CcSEcCtD
Isoniazid—Feeling abnormal—Etoposide—urinary bladder cancer	0.000158	0.00229	CcSEcCtD
Isoniazid—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000157	0.00229	CcSEcCtD
Isoniazid—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000157	0.00228	CcSEcCtD
Isoniazid—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000154	0.00223	CcSEcCtD
Isoniazid—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000152	0.00222	CcSEcCtD
Isoniazid—Jaundice—Doxorubicin—urinary bladder cancer	0.000152	0.0022	CcSEcCtD
Isoniazid—Body temperature increased—Etoposide—urinary bladder cancer	0.000151	0.0022	CcSEcCtD
Isoniazid—Hepatitis—Epirubicin—urinary bladder cancer	0.000151	0.00219	CcSEcCtD
Isoniazid—Asthenia—Cisplatin—urinary bladder cancer	0.00015	0.00218	CcSEcCtD
Isoniazid—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000145	0.00211	CcSEcCtD
Isoniazid—Vomiting—Gemcitabine—urinary bladder cancer	0.000142	0.00207	CcSEcCtD
Isoniazid—Rash—Gemcitabine—urinary bladder cancer	0.000141	0.00205	CcSEcCtD
Isoniazid—Hypersensitivity—Etoposide—urinary bladder cancer	0.000141	0.00205	CcSEcCtD
Isoniazid—Vomiting—Fluorouracil—urinary bladder cancer	0.00014	0.00203	CcSEcCtD
Isoniazid—Hepatitis—Doxorubicin—urinary bladder cancer	0.00014	0.00203	CcSEcCtD
Isoniazid—Rash—Fluorouracil—urinary bladder cancer	0.000139	0.00202	CcSEcCtD
Isoniazid—Asthenia—Etoposide—urinary bladder cancer	0.000137	0.00199	CcSEcCtD
Isoniazid—Nausea—Gemcitabine—urinary bladder cancer	0.000133	0.00193	CcSEcCtD
Isoniazid—Vomiting—Cisplatin—urinary bladder cancer	0.000133	0.00193	CcSEcCtD
Isoniazid—Rash—Cisplatin—urinary bladder cancer	0.000132	0.00191	CcSEcCtD
Isoniazid—Nausea—Fluorouracil—urinary bladder cancer	0.000131	0.0019	CcSEcCtD
Isoniazid—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00013	0.00189	CcSEcCtD
Isoniazid—Malaise—Methotrexate—urinary bladder cancer	0.000127	0.00184	CcSEcCtD
Isoniazid—Nausea—Cisplatin—urinary bladder cancer	0.000124	0.0018	CcSEcCtD
Isoniazid—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000122	0.00177	CcSEcCtD
Isoniazid—Convulsion—Methotrexate—urinary bladder cancer	0.000122	0.00177	CcSEcCtD
Isoniazid—Vomiting—Etoposide—urinary bladder cancer	0.000122	0.00177	CcSEcCtD
Isoniazid—Rash—Etoposide—urinary bladder cancer	0.000121	0.00175	CcSEcCtD
Isoniazid—Malaise—Epirubicin—urinary bladder cancer	0.000118	0.00172	CcSEcCtD
Isoniazid—Discomfort—Methotrexate—urinary bladder cancer	0.000118	0.00172	CcSEcCtD
Isoniazid—Convulsion—Epirubicin—urinary bladder cancer	0.000114	0.00165	CcSEcCtD
Isoniazid—Nausea—Etoposide—urinary bladder cancer	0.000114	0.00165	CcSEcCtD
Isoniazid—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000113	0.00164	CcSEcCtD
Isoniazid—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000112	0.00163	CcSEcCtD
Isoniazid—Discomfort—Epirubicin—urinary bladder cancer	0.00011	0.00161	CcSEcCtD
Isoniazid—Malaise—Doxorubicin—urinary bladder cancer	0.00011	0.00159	CcSEcCtD
Isoniazid—Anorexia—Methotrexate—urinary bladder cancer	0.000109	0.00159	CcSEcCtD
Isoniazid—Convulsion—Doxorubicin—urinary bladder cancer	0.000105	0.00153	CcSEcCtD
Isoniazid—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000105	0.00153	CcSEcCtD
Isoniazid—Paraesthesia—Methotrexate—urinary bladder cancer	0.000103	0.00149	CcSEcCtD
Isoniazid—Discomfort—Doxorubicin—urinary bladder cancer	0.000102	0.00149	CcSEcCtD
Isoniazid—Anorexia—Epirubicin—urinary bladder cancer	0.000102	0.00148	CcSEcCtD
Isoniazid—Dyspepsia—Methotrexate—urinary bladder cancer	0.000101	0.00147	CcSEcCtD
Isoniazid—Decreased appetite—Methotrexate—urinary bladder cancer	9.96e-05	0.00145	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	9.89e-05	0.00144	CcSEcCtD
Isoniazid—Fatigue—Methotrexate—urinary bladder cancer	9.88e-05	0.00143	CcSEcCtD
Isoniazid—Thrombocytopenia—Doxorubicin—urinary bladder cancer	9.71e-05	0.00141	CcSEcCtD
Isoniazid—Paraesthesia—Epirubicin—urinary bladder cancer	9.63e-05	0.0014	CcSEcCtD
Isoniazid—Anorexia—Doxorubicin—urinary bladder cancer	9.45e-05	0.00137	CcSEcCtD
Isoniazid—Feeling abnormal—Methotrexate—urinary bladder cancer	9.44e-05	0.00137	CcSEcCtD
Isoniazid—Dyspepsia—Epirubicin—urinary bladder cancer	9.44e-05	0.00137	CcSEcCtD
Isoniazid—Decreased appetite—Epirubicin—urinary bladder cancer	9.32e-05	0.00135	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	9.26e-05	0.00134	CcSEcCtD
Isoniazid—Fatigue—Epirubicin—urinary bladder cancer	9.24e-05	0.00134	CcSEcCtD
Isoniazid—Body temperature increased—Methotrexate—urinary bladder cancer	9.06e-05	0.00132	CcSEcCtD
Isoniazid—Paraesthesia—Doxorubicin—urinary bladder cancer	8.91e-05	0.00129	CcSEcCtD
Isoniazid—Feeling abnormal—Epirubicin—urinary bladder cancer	8.83e-05	0.00128	CcSEcCtD
Isoniazid—Dyspepsia—Doxorubicin—urinary bladder cancer	8.73e-05	0.00127	CcSEcCtD
Isoniazid—Decreased appetite—Doxorubicin—urinary bladder cancer	8.62e-05	0.00125	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	8.56e-05	0.00124	CcSEcCtD
Isoniazid—Fatigue—Doxorubicin—urinary bladder cancer	8.55e-05	0.00124	CcSEcCtD
Isoniazid—Body temperature increased—Epirubicin—urinary bladder cancer	8.47e-05	0.00123	CcSEcCtD
Isoniazid—Hypersensitivity—Methotrexate—urinary bladder cancer	8.44e-05	0.00123	CcSEcCtD
Isoniazid—Asthenia—Methotrexate—urinary bladder cancer	8.22e-05	0.00119	CcSEcCtD
Isoniazid—Feeling abnormal—Doxorubicin—urinary bladder cancer	8.17e-05	0.00119	CcSEcCtD
Isoniazid—Hypersensitivity—Epirubicin—urinary bladder cancer	7.9e-05	0.00115	CcSEcCtD
Isoniazid—Body temperature increased—Doxorubicin—urinary bladder cancer	7.84e-05	0.00114	CcSEcCtD
Isoniazid—Asthenia—Epirubicin—urinary bladder cancer	7.69e-05	0.00112	CcSEcCtD
Isoniazid—Hypersensitivity—Doxorubicin—urinary bladder cancer	7.31e-05	0.00106	CcSEcCtD
Isoniazid—Vomiting—Methotrexate—urinary bladder cancer	7.28e-05	0.00106	CcSEcCtD
Isoniazid—Rash—Methotrexate—urinary bladder cancer	7.22e-05	0.00105	CcSEcCtD
Isoniazid—Asthenia—Doxorubicin—urinary bladder cancer	7.12e-05	0.00103	CcSEcCtD
Isoniazid—Vomiting—Epirubicin—urinary bladder cancer	6.82e-05	0.00099	CcSEcCtD
Isoniazid—Nausea—Methotrexate—urinary bladder cancer	6.8e-05	0.000989	CcSEcCtD
Isoniazid—Rash—Epirubicin—urinary bladder cancer	6.76e-05	0.000982	CcSEcCtD
Isoniazid—Nausea—Epirubicin—urinary bladder cancer	6.37e-05	0.000925	CcSEcCtD
Isoniazid—Vomiting—Doxorubicin—urinary bladder cancer	6.31e-05	0.000916	CcSEcCtD
Isoniazid—Rash—Doxorubicin—urinary bladder cancer	6.25e-05	0.000909	CcSEcCtD
Isoniazid—Nausea—Doxorubicin—urinary bladder cancer	5.89e-05	0.000856	CcSEcCtD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	3.14e-05	0.000325	CbGpPWpGaD
Isoniazid—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	3.12e-05	0.000324	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	3.11e-05	0.000322	CbGpPWpGaD
Isoniazid—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.08e-05	0.000319	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	3.02e-05	0.000313	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—NAT1—urinary bladder cancer	3.02e-05	0.000313	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—SLC19A1—urinary bladder cancer	2.97e-05	0.000308	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PRSS3—urinary bladder cancer	2.89e-05	0.0003	CbGpPWpGaD
Isoniazid—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	2.87e-05	0.000297	CbGpPWpGaD
Isoniazid—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.83e-05	0.000293	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—PPARG—urinary bladder cancer	2.76e-05	0.000286	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	2.76e-05	0.000286	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	2.75e-05	0.000285	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—CREBBP—urinary bladder cancer	2.65e-05	0.000275	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	2.64e-05	0.000274	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	2.61e-05	0.00027	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—NAT1—urinary bladder cancer	2.61e-05	0.00027	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	2.56e-05	0.000266	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	2.48e-05	0.000257	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	2.45e-05	0.000254	CbGpPWpGaD
Isoniazid—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	2.41e-05	0.00025	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	2.38e-05	0.000247	CbGpPWpGaD
Isoniazid—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	2.38e-05	0.000246	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	2.35e-05	0.000243	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	2.33e-05	0.000241	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NAT1—urinary bladder cancer	2.33e-05	0.000241	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—TYMP—urinary bladder cancer	2.31e-05	0.00024	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	2.29e-05	0.000237	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	2.29e-05	0.000237	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	2.26e-05	0.000234	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	2.24e-05	0.000232	CbGpPWpGaD
Isoniazid—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	2.21e-05	0.000229	CbGpPWpGaD
Isoniazid—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.18e-05	0.000226	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—PTGS2—urinary bladder cancer	2.17e-05	0.000225	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	2.15e-05	0.000223	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	2.14e-05	0.000222	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NAT1—urinary bladder cancer	2.14e-05	0.000222	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	2.13e-05	0.000221	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	2.12e-05	0.00022	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NAT1—urinary bladder cancer	2.12e-05	0.00022	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—NAT2—urinary bladder cancer	2.09e-05	0.000217	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	2.09e-05	0.000216	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	2.03e-05	0.00021	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	1.98e-05	0.000205	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	1.96e-05	0.000203	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	1.94e-05	0.000201	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	1.92e-05	0.000199	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	1.91e-05	0.000198	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—PTEN—urinary bladder cancer	1.89e-05	0.000196	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—TYMP—urinary bladder cancer	1.83e-05	0.000189	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	1.81e-05	0.000188	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NAT1—urinary bladder cancer	1.81e-05	0.000188	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	1.81e-05	0.000188	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—EP300—urinary bladder cancer	1.81e-05	0.000187	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—RRM2—urinary bladder cancer	1.81e-05	0.000187	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.78e-05	0.000185	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	1.76e-05	0.000183	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	1.76e-05	0.000183	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	1.75e-05	0.000181	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—ENO2—urinary bladder cancer	1.67e-05	0.000173	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	1.67e-05	0.000173	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	1.66e-05	0.000173	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	1.66e-05	0.000172	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—NAT2—urinary bladder cancer	1.65e-05	0.000171	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	1.65e-05	0.000171	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	1.62e-05	0.000168	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	1.62e-05	0.000168	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	1.61e-05	0.000167	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.58e-05	0.000164	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—TYMP—urinary bladder cancer	1.58e-05	0.000164	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.52e-05	0.000157	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	1.49e-05	0.000155	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.48e-05	0.000153	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—NAT2—urinary bladder cancer	1.43e-05	0.000148	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—RRM2—urinary bladder cancer	1.43e-05	0.000148	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.41e-05	0.000147	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	1.41e-05	0.000146	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—TYMP—urinary bladder cancer	1.41e-05	0.000146	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.4e-05	0.000145	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.4e-05	0.000145	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	1.37e-05	0.000142	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.35e-05	0.00014	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—NQO1—urinary bladder cancer	1.35e-05	0.00014	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	1.32e-05	0.000137	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ENO2—urinary bladder cancer	1.32e-05	0.000137	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—TYMP—urinary bladder cancer	1.3e-05	0.000134	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.29e-05	0.000134	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.29e-05	0.000133	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	1.28e-05	0.000133	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.28e-05	0.000133	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NAT2—urinary bladder cancer	1.28e-05	0.000132	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.23e-05	0.000128	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.23e-05	0.000128	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.17e-05	0.000122	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.16e-05	0.00012	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.15e-05	0.000119	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.14e-05	0.000118	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.14e-05	0.000118	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.14e-05	0.000118	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	1.12e-05	0.000116	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.11e-05	0.000115	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.1e-05	0.000114	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—RRM2—urinary bladder cancer	1.1e-05	0.000114	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.1e-05	0.000114	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.09e-05	0.000113	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.09e-05	0.000113	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—NQO1—urinary bladder cancer	1.06e-05	0.00011	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.06e-05	0.00011	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.06e-05	0.000109	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—TYMS—urinary bladder cancer	1.04e-05	0.000108	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	1.03e-05	0.000107	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	1.03e-05	0.000107	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.02e-05	0.000106	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.02e-05	0.000106	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.01e-05	0.000105	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.01e-05	0.000105	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1e-05	0.000104	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NAT2—urinary bladder cancer	9.93e-06	0.000103	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—GPX1—urinary bladder cancer	9.89e-06	0.000103	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	9.89e-06	0.000102	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.73e-06	0.000101	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	9.71e-06	0.000101	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ENO2—urinary bladder cancer	9.38e-06	9.72e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	9.38e-06	9.72e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ENO2—urinary bladder cancer	9.29e-06	9.63e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	9.29e-06	9.63e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.24e-06	9.58e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—NQO1—urinary bladder cancer	9.21e-06	9.54e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	9.13e-06	9.46e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	9.09e-06	9.42e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	9.01e-06	9.34e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.93e-06	9.26e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	8.88e-06	9.21e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.88e-06	9.2e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—RRM2—urinary bladder cancer	8.58e-06	8.89e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—TYMP—urinary bladder cancer	8.48e-06	8.79e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—TYMS—urinary bladder cancer	8.26e-06	8.56e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NQO1—urinary bladder cancer	8.22e-06	8.52e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	8.16e-06	8.46e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	8.16e-06	8.46e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.97e-06	8.26e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	7.94e-06	8.23e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ENO2—urinary bladder cancer	7.94e-06	8.23e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.9e-06	8.18e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GPX1—urinary bladder cancer	7.82e-06	8.1e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.79e-06	8.07e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	7.7e-06	7.98e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	7.68e-06	7.96e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	7.67e-06	7.95e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NAT2—urinary bladder cancer	7.67e-06	7.95e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.59e-06	7.86e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NQO1—urinary bladder cancer	7.56e-06	7.83e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NQO1—urinary bladder cancer	7.49e-06	7.76e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.43e-06	7.7e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PPARG—urinary bladder cancer	7.4e-06	7.67e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.27e-06	7.53e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	7.21e-06	7.48e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—TYMS—urinary bladder cancer	7.14e-06	7.4e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	7.11e-06	7.37e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	7.06e-06	7.31e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	7.06e-06	7.31e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.95e-06	7.2e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	6.85e-06	7.1e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GPX1—urinary bladder cancer	6.76e-06	7e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	6.63e-06	6.87e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.63e-06	6.87e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—RRM2—urinary bladder cancer	6.62e-06	6.86e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NQO1—urinary bladder cancer	6.4e-06	6.63e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—TYMS—urinary bladder cancer	6.37e-06	6.6e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.34e-06	6.57e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	6.3e-06	6.53e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	6.3e-06	6.53e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	6.3e-06	6.53e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	6.25e-06	6.48e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	6.24e-06	6.46e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.21e-06	6.44e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ENO2—urinary bladder cancer	6.13e-06	6.35e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	6.13e-06	6.35e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.05e-06	6.27e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GPX1—urinary bladder cancer	6.03e-06	6.25e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	5.95e-06	6.16e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	5.92e-06	6.14e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—TYMS—urinary bladder cancer	5.86e-06	6.07e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PPARG—urinary bladder cancer	5.85e-06	6.06e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	5.82e-06	6.03e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—TYMS—urinary bladder cancer	5.81e-06	6.02e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	5.79e-06	6e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	5.79e-06	6e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	5.74e-06	5.95e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	5.74e-06	5.95e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	5.62e-06	5.82e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	5.57e-06	5.77e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GPX1—urinary bladder cancer	5.55e-06	5.75e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GPX1—urinary bladder cancer	5.5e-06	5.7e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	5.45e-06	5.64e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.42e-06	5.61e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	5.4e-06	5.59e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	5.34e-06	5.53e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.17e-06	5.35e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	5.12e-06	5.31e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PTEN—urinary bladder cancer	5.08e-06	5.26e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	5.07e-06	5.26e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PPARG—urinary bladder cancer	5.06e-06	5.24e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—TYMS—urinary bladder cancer	4.96e-06	5.14e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NQO1—urinary bladder cancer	4.94e-06	5.12e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	4.91e-06	5.09e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	4.91e-06	5.09e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	4.86e-06	5.03e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—EP300—urinary bladder cancer	4.84e-06	5.02e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GPX1—urinary bladder cancer	4.7e-06	4.87e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	4.61e-06	4.78e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	4.6e-06	4.77e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PPARG—urinary bladder cancer	4.51e-06	4.68e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	4.34e-06	4.49e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	4.34e-06	4.49e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PPARG—urinary bladder cancer	4.15e-06	4.3e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	4.12e-06	4.27e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PPARG—urinary bladder cancer	4.12e-06	4.26e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PTEN—urinary bladder cancer	4.01e-06	4.16e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	3.99e-06	4.13e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	3.98e-06	4.12e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	3.95e-06	4.1e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—TYMS—urinary bladder cancer	3.83e-06	3.97e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—EP300—urinary bladder cancer	3.83e-06	3.97e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	3.79e-06	3.92e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	3.79e-06	3.92e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GPX1—urinary bladder cancer	3.63e-06	3.76e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	3.56e-06	3.69e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	3.55e-06	3.68e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PPARG—urinary bladder cancer	3.52e-06	3.64e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PTEN—urinary bladder cancer	3.47e-06	3.59e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	3.38e-06	3.5e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	3.35e-06	3.47e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—EP300—urinary bladder cancer	3.31e-06	3.43e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	3.27e-06	3.38e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	3.24e-06	3.35e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PTEN—urinary bladder cancer	3.1e-06	3.21e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—EP300—urinary bladder cancer	2.95e-06	3.06e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PTEN—urinary bladder cancer	2.85e-06	2.95e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PTEN—urinary bladder cancer	2.82e-06	2.93e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	2.77e-06	2.87e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—EP300—urinary bladder cancer	2.72e-06	2.81e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PPARG—urinary bladder cancer	2.71e-06	2.81e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—EP300—urinary bladder cancer	2.69e-06	2.79e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	2.61e-06	2.7e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PTEN—urinary bladder cancer	2.41e-06	2.5e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—EP300—urinary bladder cancer	2.3e-06	2.38e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.13e-06	2.21e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.86e-06	1.93e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.78e-06	1.84e-05	CbGpPWpGaD
